Antenatal corticosteroids linked to higher infection risk throughout childhood

Publicly released:
Australia; International; NSW; VIC
Photo by Alicia Petresc on Unsplash
Photo by Alicia Petresc on Unsplash

Medications given to women considered at risk of preterm birth are linked to an increased risk of infections throughout the baby's childhood, according to Australian researchers who say this link does not apply to very preterm births. Antenatal corticosteroids are prescribed when a preterm birth is anticipated to help the baby develop and improve its chance of survival. Studying a cohort of 1.5 million mother-child pairs including 50,000 antenatal corticosteroid-exposed pregnancies, the researchers say children born at 34 weeks or longer went on to develop more respiratory and non-respiratory infections throughout their childhood and teens. However, they say there was no link between the medication and infection risk for babies born earlier than 34 weeks. The researchers say this indicates we may need to improve preterm birth prediction strategies to be more discerning about who is prescribed these corticosteroids.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Network Open
Research:Paper
Organisation/s: Murdoch Children's Research Institute (MCRI), The University of Melbourne, The University of New South Wales, Burnet Institute, University of Edinburgh, UK
Funder: The Consortium for the Study of Pregnancy Treatments collaboration and Dr Stock were funded by aWellcome Trust Clinical Career Development Fellowship (award 209560/Z/17/Z). Dr Decrue was supported by the Swiss National Science Foundation (award P500PM_206634) and the Bangerter-Rhyner Foundation. Dr Reynolds was supported by the British Heart Foundation (award RE/18/5/34216). Dr Lahti- Pulkkinen was supported by the Academy of Finland (award 330206). Dr Boegaert was funded by the Chief Scientist Office/National Health Service Research Scotland Scottish Senior Clinical Fellowship (award SCAF/16/03). Dr Burgner was supported by a National Health and Medical Research Council Investigator Grant (award GTN1175744).
Media Contact/s
Contact details are only visible to registered journalists.